Table 2.
Additional secondary endpoints
| Endpoint | |
|---|---|
| 1 | Change from baseline to the average of weeks 12–28 in FACT-An |
| 2 | Change from baseline to the average of weeks 12–28 in EQ-5D-5L |
| 3 | Change from baseline to the average of weeks 12–28 in PGIC |
| 4 | Occurrence and duration of hospitalizations |
| 5 | Serum hepcidin |
| 6 | Serum ferritin |
| 7 | Transferrin saturation |
EQ-5D-5L European Quality of Life 5-Dimension 5-Level, FACT-An Functional Assessment of Cancer Therapy-Anemia, PGIC Patients’ Global Impression of Change